扩展核酸 (exNA):一种新的,生物相容的脊柱,可以显著提高寡核酸的有效性
Ken Yamada1, Vignesh Narayan Hariharan1, Jillian Caiazzi1
1RNA Therapeutics Institute, University of Massachusetts Chan Medical School, 368 Plantation Street, Worcester, Massachusetts 01605, United States.
研究人员开发了扩展核酸 (exNA),这是治疗性寡核酸的新型骨干. 这种exNA骨干显著提高了稳定性和体内疗效,扩大了治疗可能性.
科学领域:
- 橄核酸的化学成分
- 药物的发现和开发.
背景情况:
- 治疗性寡核酸需要脊柱修改以实现代谢稳定.
- 酸 (PS) 目前是唯一临床使用的骨干化学物质.
结论:
- exNA结合改善了siRNAs的体内疗效,增强了组织暴露 (约6倍) 和积累 (4至20倍).
- 经 exNA 改性寡核酸的强效和耐久性增加,扩大了治疗应用和组织向的范围.
- exNA代表了基于寡核酸的治疗方法的有希望的进步,使新的治疗策略成为可能.
更多相关视频
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
03:38Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
相关概念视频
Long-patch Base Excision Repair
Nuclear Overhauser Enhancement (NOE)
Nucleic Acid Structure
DNA Structure
DNA...
Base Excision Repair
The first step of...
Nucleotide Excision Repair
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
